The 2019 ESICM LIVES Congress in Berlin, hosted by the European Society of Intensive Care Medicine, was yet again a draw for over 6,000 physicians, anesthetists, nurses and other health care professionals – whether they are veterans in their field or trainees.
Berlin’s CityCube Congress Center was lined with exhibitors showcasing their latest developments in their field. While some used patient dummies, others had real people as mock-patients for putting their devices into action.
Physicians Shared Their Experiences at AMOMED Symposium
On October 1, AMOMED invited the participants of the congress to join our symposium on Precision and Balance without Compromise.
The symposium was chaired by Prof. Bruno Levy (Centre Hospitalier Universitaire de Nancy, France) and Prof. Matthias Heringlake (University Clinic Schleswig-Holstein, Germany) and covered the following topics:
- Precise heart rate control – the Japanese experience with landiolol – Speaker: Koichiro Kinugawa (Toyama, Japan)
- Balancing vasopressors in vasodilatory shock: The role of argipressin – Speaker: Ludhmila Abrahao Hajjar (Sao Paulo, Brazil)
- Management of high-risk cardiac surgery patients – The clinical perspective – Speaker: Matthias Heringlake (Lübeck, Germany) and Erich Kilger (Munich, Germany)
Prof. Kinugawa (pictured here with AMOMED Medical Director France & Head of Strategic Business Development and Technology Transfer Olivier Bouvet) presented, among other information, new data about precise heart rate control as well as recommendations for rate control management during atrial fibrillation.
Prof. Hajjar focused on several studies including the VANCS study, the VANISH randomized trial and the VANCS II trial. She closed by stating that vasopressin deserves to be explored in the setting of pulmonary hypertension.
Prof. Heringlake and Prof. Kilger explored the factors influencing outcomes of cardiac surgery and offered insights with clinical cases (case vignettes) on rhythm management of high-risk cardiac surgery patients.
In between the presentations, Prof. Heringlake asked the audience to participate to vote via an App on various questions asked about the topic at hand and how they treat patients in certain clinical settings. The results of the poll were shown on screen in real time.
If you would like to know more about the details of each presentation, please feel free to contact us at office@amomed.com or +43 1 545 01 130. We are happy to share this information.
AMOMED‘s Offer for the Intensive Care Medicine Community
AMOMED offers medical products which can be used in cases of cardiac arrhythmia, myocardial infarction or sepsis. Learn more or contact us at office@amomed.com or +43 1 545 01 130.